Soluble CD163 as a biomarker for renal involvment in systemic lupus erythematosus patients

Urinary CD25 as a Biomarker of Lupus Nephritis Activity in Pediatrics

The Role of T-cell Immunoglobulin and Mucin Domain-Containing Molecule-3 as Disease Activity Marker in Systemic Lupus Erythematosus

SERUM INTERLEUKIN-18 AS A NOVEL BIOMARKER FOR DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

The Possible Role of Urinary Matrix Metalloproteinase 7 as an Early Predictor of Lupus Nephritis Flares in Systemic Lupus Erythematosus Patients

Serum interleukin 29 in Rheumatoid Arthritis and Systemic Lupus Erythematosus patients and its association with disease activity.

Serum levels of soluble CD95 in patients with systemic lupus erythematosus

Serum lipoxin A4 as a biomarker for systemic lupus erythematosus

Circulating IL 6 and IL 23 Levels in Systemic Lupus Erythematosus Patients and Association with Disease Activity

Clinical Correlates of Soluble sCD163 and IL9 in Patients with Chronic Kidney Disease and Lupus Nephritis